ACCESSION: MSBNK-SMB_Measured-HSA001P0193004
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 64
COMMENT: RAW_SPEC {'BLK01_16725': {'bp': 227656.0, 'sum': 554308.0}, '16_posi_16791': {'bp': 180106.0, 'sum': 521964.0}, '14_posi_16538': {'bp': 190042.0, 'sum': 498132.0}, 'BLK02_16687': {'bp': 198240.0, 'sum': 523187.0}, '19_posi_16537': {'bp': 181286.0, 'sum': 457853.0}, '5_posi_17255': {'bp': 126827.0, 'sum': 419232.0}, '3_posi_16938': {'bp': 156062.0, 'sum': 489053.0}, '6_posi_16601': {'bp': 157045.0, 'sum': 458048.0}, '12_posi_16795': {'bp': 157977.0, 'sum': 446753.0}, '4_posi_16916': {'bp': 176097.0, 'sum': 512420.0}, '16_posi_16498': {'bp': 195567.0, 'sum': 531192.0}, '17_posi_16938': {'bp': 128288.0, 'sum': 403676.0}, '3_posi_17130': {'bp': 156748.0, 'sum': 509913.0}, '5_posi_16893': {'bp': 181006.0, 'sum': 511208.0}, '2_posi_16745': {'bp': 190014.0, 'sum': 561796.0}, 'ProcedureBlank_16622': {'bp': 216245.0, 'sum': 544144.0}, '2_posi_17147': {'bp': 160127.0, 'sum': 475806.0}, 'ProcedureBlank_17315': {'bp': 176161.0, 'sum': 512319.0}, '7_posi_16980': {'bp': 153026.0, 'sum': 462895.0}, '6_posi_17128': {'bp': 156030.0, 'sum': 450353.0}, '5_posi_16793': {'bp': 156110.0, 'sum': 475248.0}, '11_posi_16913': {'bp': 160564.0, 'sum': 484689.0}, '17_posi_16580': {'bp': 182855.0, 'sum': 480502.0}, '1_posi_16643': {'bp': 217613.0, 'sum': 542027.0}, '10_posi_16958': {'bp': 134230.0, 'sum': 420415.0}, '9_posi_17338': {'bp': 138802.0, 'sum': 456118.0}, '16_posi_16351': {'bp': 199471.0, 'sum': 487659.0}, '8_posi_17144': {'bp': 146374.0, 'sum': 494094.0}, 'ProcedureBlank_17125': {'bp': 166494.0, 'sum': 501504.0}, '16_posi_17124': {'bp': 145815.0, 'sum': 446321.0}, '13_posi_17231': {'bp': 135876.0, 'sum': 416177.0}, '6_posi_16958': {'bp': 187284.0, 'sum': 508127.0}, '6_posi_17316': {'bp': 134865.0, 'sum': 466651.0}, '13_posi_16978': {'bp': 147923.0, 'sum': 442628.0}, '11_posi_16646': {'bp': 193097.0, 'sum': 542345.0}, '4_posi_17295': {'bp': 147902.0, 'sum': 460127.0}, '3_posi_17251': {'bp': 148379.0, 'sum': 464634.0}, '7_posi_17337': {'bp': 143379.0, 'sum': 448714.0}, '11_posi_16976': {'bp': 144127.0, 'sum': 431722.0}, 'ProcedureBlank_17378': {'bp': 175436.0, 'sum': 504445.0}, '15_posi_17085': {'bp': 125894.0, 'sum': 394478.0}, '8_posi_17065': {'bp': 155000.0, 'sum': 497995.0}, '17_posi_16411': {'bp': 207686.0, 'sum': 512757.0}, '3_posi_16704': {'bp': 183681.0, 'sum': 474964.0}, 'BLK02_16622': {'bp': 213166.0, 'sum': 512709.0}, 'ProcedureBlank_16685': {'bp': 202740.0, 'sum': 543506.0}, '4_posi_16748': {'bp': 178760.0, 'sum': 521816.0}, '6_posi_17226': {'bp': 155812.0, 'sum': 469301.0}, '15_posi_16899': {'bp': 137737.0, 'sum': 400884.0}, '5_posi_17399': {'bp': 136464.0, 'sum': 483309.0}, '10_posi_16414': {'bp': 194097.0, 'sum': 510422.0}, '3_posi_16454': {'bp': 189662.0, 'sum': 478035.0}, '8_posi_16581': {'bp': 181585.0, 'sum': 495382.0}, '10_posi_16875': {'bp': 166255.0, 'sum': 490188.0}, '1_posi_17170': {'bp': 159703.0, 'sum': 529871.0}, '14_posi_16644': {'bp': 154316.0, 'sum': 472782.0}, '10_posi_17062': {'bp': 132878.0, 'sum': 417016.0}, 'BLK02_16960': {'bp': 207531.0, 'sum': 525132.0}, '12_posi_16894': {'bp': 159267.0, 'sum': 473335.0}, '12_posi_16666': {'bp': 157816.0, 'sum': 466645.0}, 'ProcedureBlank_16978': {'bp': 182219.0, 'sum': 533371.0}, '14_posi_16454': {'bp': 198538.0, 'sum': 498182.0}, '6_posi_16770': {'bp': 164649.0, 'sum': 484816.0}, '1_posi_16856': {'bp': 185018.0, 'sum': 518581.0}}
COMMENT: RETENTION_TIME_STDEV 0.561
COMMENT: PRECURSOR_M/Z_RAW 193.144333
COMMENT: PRECURSOR_M/Z_STDEV 0.000115
COMMENT: PRECURSOR_IN_MS1 mz 193.144639; int 25.948; delta(ppm) 0.911172
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.682; C10H16N4; [M+H]+; delta(ppm) -0.681804
COMMENT: PROPOSED_MF MS-FINDER 2.673; C10H16N4; [M+H]+; delta(ppm) -0.678102
COMMENT: PROPOSED_MF SIRIUS5_Sirius 15.281; C10H16N4; [M+H]+; delta(ppm) -0.678102
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2.897; C9H20O4; [M+H]+; delta(ppm) 6.246353
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H16N4; [M+H]+; delta(ppm) -0.678102
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.807; C10H16N4; [M+H]+; delta(ppm) -0.678102
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.725; C7H17FN4O; [M+H]+; delta(ppm) -6.594112
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.939; C9H20O4; [M+H]+; delta(ppm) 6.246353
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.844; C8H21N2OP; [M+H]+; delta(ppm) -9.229985
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.368; C12H18NO; [M+H]+; delta(ppm) -7.629641
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.707; C6H19N5P; [M+H]+; delta(ppm) -2.278469
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H16N4; [M+H]+; delta(ppm) -0.678102
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.763; NTAYHZGUFNPVLG-UHFFFAOYSA-N; [M+H]+; N1=CNC2=C1C3(NCC2)CCNCC3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.690; OIFIPRUEJLZKTO-UHFFFAOYSA-N; [M+H]+; N#CCN1CCCN(CC#N)CCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.680; AVTLBBWTUPQRAY-UHFFFAOYNA-N; [M+H]+; CCC(C)(N=NC(C)(CC)C#N)C#N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.561; NTAYHZGUFNPVLG-UHFFFAOYSA-N; [M+H]+; 1,5,6,7-tetrahydrospiro[imidazo[4,5-c]pyridine-4,4'-piperidine]
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.370; AVTLBBWTUPQRAY-UHFFFAOYNA-N; [M+H]+; 2,2'-azobis[2-methylbutyronitrile]
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.370; OIFIPRUEJLZKTO-UHFFFAOYSA-N; [M+H]+; 2-[5-(cyanomethyl)-1,5-diazocan-1-yl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NTAYHZGUFNPVLG-UHFFFAOYSA-N; [M+H]+; 1,5,6,7-tetrahydrospiro[imidazo[4,5-c]pyridine-4,4'-piperidine]
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.385; OIFIPRUEJLZKTO-UHFFFAOYSA-N; [M+H]+; 2-[5-(cyanomethyl)-1,5-diazocan-1-yl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.230; AVTLBBWTUPQRAY-UHFFFAOYNA-N; [M+H]+; 2,2'-azobis[2-methylbutyronitrile]
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.509; AVTLBBWTUPQRAY-UHFFFAOYSA-N; [M+H]+; 2-(2-cyanobutan-2-yldiazenyl)-2-methylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.299; QXQYJEMSNUMUPO-UHFFFAOYSA-N; [M+H]+; 3-[4-(2-cyanoethyl)piperazin-1-yl]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.978; QUWILARGNKEHLL-UHFFFAOYSA-N; [M+H]+; 2-(3-phenylpropylamino)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.653; UAJACUSQLFALEQ-UHFFFAOYSA-N; [M+H]+; 4-(4-methylpiperazin-1-yl)pyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.479; IFHQJBQZOLOOHW-UHFFFAOYSA-N; [M+H]+; 2-(4-methylpiperazin-1-yl)pyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.399; NARMKNJWXHFJFF-UHFFFAOYSA-N; [M+H]+; 2,4-dimethyl-6-piperazin-1-ylpyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.393; QLTXFTSBONWMPM-UHFFFAOYSA-N; [M+H]+; 4,6-dimethyl-2-piperazin-1-ylpyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.387; VUSGWKQMYKIPCN-UHFFFAOYSA-N; [M+H]+; 4-(3-cyclopropyl-1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; HLPCCWWWGIAENW-UHFFFAOYSA-N; [M+H]+; (6-methyl-2-pyrrolidin-1-ylpyrimidin-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.329; NZTCEWZBMOTKCJ-UHFFFAOYSA-N; [M+H]+; 6-(4-methylpiperazin-1-yl)pyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.327; MATMXHKMDSPCSZ-UHFFFAOYSA-N; [M+H]+; 1-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.325; ZADAPLCYCBLHPU-UHFFFAOYSA-N; [M+H]+; (1-pyrimidin-2-ylpiperidin-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.325; SOQIYEUEAKMJCJ-UHFFFAOYSA-N; [M+H]+; (1-pyrimidin-4-ylpiperidin-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.320; WZODRKCBBZZALX-UHFFFAOYSA-N; [M+H]+; 2-(4-methylpiperazin-1-yl)pyridin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.319; ZTOPKLNHHKKXNY-UHFFFAOYSA-N; [M+H]+; 5-(4-methylpiperazin-1-yl)pyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.319; ZUJQQYHJZCPPEX-UHFFFAOYSA-N; [M+H]+; 6-[3-(dimethylamino)azetidin-1-yl]pyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.311; NNOWKRZSPSNRCP-UHFFFAOYSA-N; [M+H]+; 2-[2-(N-methylanilino)ethyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.310; IGTZGQVCOZRJMJ-UHFFFAOYSA-N; [M+H]+; 1-(6-methylpyrimidin-4-yl)piperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.310; PPYXVCIIADJKCY-UHFFFAOYSA-N; [M+H]+; 7-ethyl-5,6,8,9-tetrahydropyrazino[2,3-d]azepin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.310; KZDVRUBEWMFQOK-UHFFFAOYSA-N; [M+H]+; 1-(6-methylpyrimidin-4-yl)piperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.306; UXJXGDDZKLKKEW-UHFFFAOYSA-N; [M+H]+; 1-(2-methylpyrimidin-4-yl)piperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.177; JCUCNDMQNLNEFI-UHFFFAOYSA-N; [M+H]+; N-(2,3,5-trimethylpyrrol-1-yl)-4,5-dihydro-1H-imidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.145; GXUANFDVJSTLSO-UHFFFAOYSA-N; [M+H]+; 1,1-dimethyl-2-(2-methylanilino)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.119; QDMPMBFLXOWHRY-UHFFFAOYSA-N; [M+H]+; 5-(4-methylpiperazin-1-yl)pyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.110; SBHJKIRVTPGZOV-UHFFFAOYSA-N; [M+H]+; 6-(4-methylpiperazin-1-yl)pyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.104; LLYCLVPZTUNJRJ-UHFFFAOYSA-N; [M+H]+; 4-(4-methylpiperazin-1-yl)pyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.098; BNVDMMSAVKWLAF-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-6-pyrrolidin-2-ylpyridazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.097; AESSZJUKVJPBNZ-UHFFFAOYSA-N; [M+H]+; N-methyl-N-piperidin-4-ylpyridazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.089; WZVBRSOPHVMUEQ-VIFPVBQESA-N; [M+H]+; 3-[[(2S)-2-methylpiperazin-1-yl]methyl]pyridazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.072; GFGONAYUFGGPDH-UHFFFAOYSA-N; [M+H]+; 3-pyrrolidin-3-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.072; SRNJTVMJFGYBPH-QMMMGPOBSA-N; [M+H]+; 3-[(2S)-pyrrolidin-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.065; BEIZNDOIXVPSTJ-UHFFFAOYSA-N; [M+H]+; 1-(5-cyclopropyl-1H-pyrazol-3-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.059; XPDSIWFKRJJSHS-UHFFFAOYSA-N; [M+H]+; 6-methyl-N-piperidin-4-ylpyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; GRUYWRRKXBOGDW-UHFFFAOYSA-N; [M+H]+; 3-cyclopentyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.057; FBPVFPCEAXIBSB-DTWKUNHWSA-N; [M+H]+; 5-[(3S,4S)-4-cyclopropylpyrrolidin-3-yl]-3-methyl-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; IPVGRNQKIDXDMG-UHFFFAOYSA-N; [M+H]+; 2-(2-piperazin-1-ylethyl)pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; RCPGWBRVUXPUSD-UHFFFAOYSA-N; [M+H]+; 1-(6-methylpyridazin-3-yl)-1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; PLXWEVMKYRZMMI-UHFFFAOYSA-N; [M+H]+; 3-piperidin-3-yl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; KFGHIVUUNGDEIR-UHFFFAOYSA-N; [M+H]+; 3-piperidin-4-yl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.041; RJUPSUBVSQEGME-UHFFFAOYSA-N; [M+H]+; 8-(1,2,4-triazol-4-ylmethyl)-6-azaspiro[3.4]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; XESVQSUDOVRMKL-VQHVLOKHSA-N; [M+H]+; [(6E)-6-(dimethylaminomethylidene)-2,3,4,5-tetrahydroazepin-7-yl]cyanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.582; YUORAWUIGVUNLY-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1-pyridazin-3-ylpyrrolidin-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.582; DEMPYJPTIIPUNY-UHFFFAOYSA-N; [M+H]+; N-methyl-1-pyridazin-3-ylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.575; ZORBHPKWEBTNPG-UHFFFAOYSA-N; [M+H]+; N-methyl-1-pyrazin-2-ylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -105.171; QXQYJEMSNUMUPO; [M+H]+; Bis(cyanoethyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -111.543; QLTXFTSBONWMPM; [M+H]+; 4,6-dimethyl-2-piperazinylpyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -126.332; NZTCEWZBMOTKCJ; [M+H]+; 6-(4-methylpiperazino)-3-pyridinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -128.675; IFHQJBQZOLOOHW; [M+H]+; 2-(4-methylpiperazino)-3-pyridinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -130.635; QDMPMBFLXOWHRY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.121; OIFIPRUEJLZKTO; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -158.353; UAJACUSQLFALEQ; [M+H]+; 1-(3-Amino-4-pyridyl)-4-methylpiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -165.302; IPVGRNQKIDXDMG; [M+H]+; Pyrazine, [2-(1-piperazinyl)ethyl]-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.960; KFGHIVUUNGDEIR; [M+H]+; 4-{5H,6H,7H-pyrrolo[2,1-c][1,2,4]triazol-3-yl}piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -228.023; AVTLBBWTUPQRAY; [M+H]+; VAZO&trade; 67
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.600; NTAYHZGUFNPVLG; [M+H]+; 1,5,6,7-tetrahydrospiro[imidazo[4,5-c]pyridine-4,4''-piperidine]
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -306.864; NNOWKRZSPSNRCP; [M+H]+; (2-(N-Methylanilino)ethyl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.944; QUWILARGNKEHLL; [M+H]+; (3-Phenylpropyl)aminoguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -355.235; GXUANFDVJSTLSO; [M+H]+; N,N-Dimethyl-2-(2-methylphenyl)hydrazinecarboximidamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -405.115; XESVQSUDOVRMKL; [M+H]+; 2-(N-Cyanimino)-3-dimethylaminoethylenehexahydroazepine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.248; QXQYJEMSNUMUPO; [M+H]+; Bis(cyanoethyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -74.539; SEYFJUIAGZDSLX; [M+H]+; 4-ethyl-1-[(1Z,3Z)-penta-1,3-dienyl]pyrazole-3,5-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -76.033; HAQDLNGBOSYNSD; [M+H]+; 2-Amino-2-methyl-3-(3,4,5-trimethylpyrazol-1-yl)propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -77.589; CKIOPGAPSKRKSL; [M+H]+; 2-(5-Cyclopropyl-1-ethylpyrazol-4-yl)ethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -78.373; SLAYDRWAHQMNPX; [M+H]+; 3-(4-Amino-3,5-diethylpyrazol-1-yl)propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -79.238; UUBCIUXMVBLQFR; [M+H]+; 2-(3-Cyclopropyl-1-ethylpyrazol-4-yl)ethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -80.032; XBBVFTVAVHLIGU; [M+H]+; 1-Ethyl-3-propyl-4,7-dihydropyrazolo[4,3-d]pyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -81.102; WASZGNYCZCSCQS; [M+H]+; 2-(2-Methyl-4,5,6,7-tetrahydrobenzimidazol-1-yl)ethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -81.585; IAXXKCRGZBQUOB; [M+H]+; 3-Cyclopropyl-1-propylpyrazole-4-carboximidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -82.092; VWCLAGZJLOTAFB; [M+H]+; N'-[2-(4-methylpyrazol-1-yl)ethyl]cyclopropanecarboximidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -82.482; QVEMRBYMFVFPJF; [M+H]+; N'-cyclopropyl-N-(2-ethylpyrazol-3-yl)ethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.068; SEYFJUIAGZDSLX; [M+H]+; 4-ethyl-1-[(1Z,3Z)-penta-1,3-dienyl]pyrazole-3,5-diamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C10H17N4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 33.913
MS$FOCUSED_ION: PRECURSOR_M/Z 193.144642
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-0900000000-330b9612ce8bf5d8eeb8
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  59.0490721 69.8926 59.049710 1.2701 15.99 0.1741 64 ?
  97.0759100 53.5813 97.076255 1.4319 11.25 0.5259 64 f{C5H9N2}/-1.18ppm,p-C5H8N2
  122.0711374 56.9137 122.071220 1.5729 14.78 0.2331 64 f{C6H8N3}/-1.12ppm,p-C4H9N1
  123.0553657 146.9438 123.055435 1.1133 24.90 0.4572 64 ?
  123.0915762 31.1633 123.091645 2.6403 7.70 0.4065 48 f{C7H11N2}/-0.80ppm,p-C3H6N2
  125.0708986 88.8763 125.070940 1.6311 18.78 0.2433 64 ?
  165.1133119 65.6926 165.113200 1.9623 18.39 -0.0950 64 f{C8H13N4}/-0.97ppm,p-C2H4
  175.1480883 110.5849 175.147970 1.7071 41.99 -0.3624 64 ?
  176.1181289 82.7329 176.118010 2.1349 15.65 0.5909 63 f{C10H14N3}/-0.54ppm,p-H3N1
  193.0716296 42.0400 193.071500 2.6467 13.38 -0.1769 60 ?
  193.1085346 662.9285 193.108405 0.5386 96.21 0.3274 64 ?
  193.1445696 999.0000 193.144440 1.1701 0.00 1.0000 64 f{C10H17N4}/-1.05ppm,p
  193.1592796 158.4456 193.159150 1.4755 65.47 -0.3003 63 ?
PK$NUM_PEAK: 13
PK$PEAK: m/z int. rel.int.
  59.049072 69.89 69
  97.075910 53.58 53
  122.071137 56.91 56
  123.055366 146.94 146
  123.091576 31.16 31
  125.070899 88.88 88
  165.113312 65.69 65
  175.148088 110.58 110
  176.118129 82.73 82
  193.071630 42.04 42
  193.108535 662.93 662
  193.144570 999.00 999
  193.159280 158.45 158
//
